Roddie, C., O’Reilly, M., Dias Alves Pinto, J., Vispute, K., Lowdell, M. Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy. March 2019; 21(3), 327-340. doi: 10.1016/j.jcyt.2018.11.009
Read MoreMathew, A. J. Biopreservation Considerations for Regenerative Medicine GMP Manufacturing; 2018. http://ebook.liebertpub.com/biolife-solutions/biopreservation-considerations-for-regenerative-medicine-gmp-manufacturing
Read MoreMathew, A. J. Biopreservation Considerations for Regenerative Medicine GMP Manufacturing; 2018. http://ebook.liebertpub.com/biolife-solutions/biopreservation-considerations-for-regenerative-medicine-gmp-manufacturing
Read MoreLiaskou, E., Patel, S. R., Webb, G., Bagkou Dimakou, D., Akiror, S., Krishna, M., Mells, G., Jones, D. E., Bowman, S. J., Barone, F., Fisher, B. A. and Hirschfield, G. M. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells. Journal Of Autoimmunity (2018). doi:10.1016/j.jaut.2018.07.020
Read MoreBarrachina, L., Romero, A., Zaragoza, P., Rodellar, C., Vázquez, F. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse. The Veterinary Journal. 2018; 238, 49-57. doi:10.1016/j.tvjl.2018.07.004
Read MoreBarrachina, L., Romero, A., Zaragoza, P., Rodellar, C., Vázquez, F. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse. The Veterinary Journal. 2018; 238, 49-57. doi:10.1016/j.tvjl.2018.07.004
Read MoreAijaz, A., Li, M., Smith, D., Khong, D., LeBlon, C., Fenton, O. S., Olabisi, R. M., Libutti, S., Tischfield, J., Maus, M. V., Deans, R., Barcia, R. N., Anderson, D. G., Ritz, J., Preti, R., Parekkadan, B. Biomanufacturing for clinically advanced cell therapies. Nature Biomedical Engineering 2018; 2(6), 362-376. doi:10.1038/s41551-018-0246-6
Read MoreHung, C., Xu, X., Li, L., Ma, Y., Jin, Q., Viley, A., Allen, C., Natarajan, P., Shivakumar, R., Peshwa, M. V. and Emens, L. A. Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy. Human Gene Therapy. 2018; 29(5), 614-625. doi:10.1089/hum.2017.080
Read MoreMcCreedy, B. J., Senyukov, V. V., Nguyen, K. T. Off the shelf T cell therapies for hematologic malignancies. Best Practice & Research Clinical Haematology 2018; 31(2), 166-175. doi: 10.1016/j.beha.2018.03.001.
Read MoreBaust, Campbell, Harbell. Best practices for cryopreserving, thawing, recovering, and assessing cells. In Vitro Cell.Dev.Biol.—Animal. DOI 10.1007/s11626-017-0201-y
Read More